Comparison of the Clinical Efficacy and Safety of Subcutaneous Versus Oral Administration of Methotrexate in Patients with Active Rheumatoid Arthritis: Results of a Six-Month, Multicenter, Randomized, Double- Blind, Controlled, Phase IV Trial

被引：0
|
作者：
Brezinschek, Hans-Peter [1 ]
机构：
[1] Med Univ Graz, Univ Klin Innere Med, Klin Abt Rheumatol, Auenbruggerplatz 15, A-8036 Graz, Austria
来源：
JOURNAL FUR MINERALSTOFFWECHSEL | 2008年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：106 / 107
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial
    Zhang, Xiaoying
    Miao, Miao
    Zhang, Ruijun
    Liu, Xu
    Zhao, Xiaozhen
    Shao, Miao
    Liu, Tian
    Jin, Yuebo
    Chen, Jiali
    Liu, Huixin
    Zhang, Xia
    Li, Yun
    Zhou, Yunshan
    Yang, Yue
    Li, Ru
    Yao, Haihong
    Liu, Yanying
    Li, Chun
    Li, Yuhui
    Ren, Limin
    Su, Yin
    Sun, Xiaolin
    He, Jing
    Li, Zhanguo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [32] Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial
    Xiaoying Zhang
    Miao Miao
    Ruijun Zhang
    Xu Liu
    Xiaozhen Zhao
    Miao Shao
    Tian Liu
    Yuebo Jin
    Jiali Chen
    Huixin Liu
    Xia Zhang
    Yun Li
    Yunshan Zhou
    Yue Yang
    Ru Li
    Haihong Yao
    Yanying Liu
    Chun Li
    Yuhui Li
    Limin Ren
    Yin Su
    Xiaolin Sun
    Jing He
    Zhanguo Li
    Signal Transduction and Targeted Therapy, 7
  • [33] Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
    Keystone, EC
    Schiff, MH
    Kremer, JM
    Kafka, S
    Lovy, M
    DeVries, T
    Burge, DJ
    ARTHRITIS AND RHEUMATISM, 2004, 50 (02): : 353 - 363
  • [34] Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study
    Yang, Yue
    Li, Jingyang
    Liu, Ju
    Liu, Lin
    Wang, Yongfu
    Hu, Jiankang
    Li, Zhijun
    Gu, Jieruo
    Zhang, Xiao
    Xiao, Zhengyu
    Zheng, Junjie
    Liu, Lin
    Li, Zhanguo
    Wei, James Cheng-Chung
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2024, 42
  • [35] Effectiveness of Yishen Tongbi decoction versus methotrexate in patients with active rheumatoid arthritis: A double-blind, randomized, controlled, non-inferiority trial
    Xu, Jia
    Zhang, Lu
    Xu, Yanping
    Yu, Jiahui
    Zhao, Lianyu
    Deng, Hui
    Li, Meiling
    Zhang, Mingying
    Lei, Xujie
    Hu, Congqi
    Jiao, Wei
    Dai, Zhao
    Liu, Lijuan
    Chen, Guangxing
    PHYTOMEDICINE, 2023, 112
  • [36] A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis
    Zhang, Ling-Ling
    Wei, Wei
    Xiao, Feng
    Xu, Jian-Hua
    Bao, Chun-De
    Ni, Li-Qing
    Li, Xing-Fu
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (07): : 905 - 910
  • [37] A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis
    Abe, T
    Takeuchi, T
    Miyasaka, N
    Hashimoto, H
    Kondo, H
    Ichikawa, Y
    Nagaya, L
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 37 - 44
  • [38] Safety and Efficacy Of Subcutaneous Golimumab In Chinese Patients With Active Rheumatoid Arthritis Despite MTX Therapy: Results From a Randomized, Placebo-Controlled, Phase 3 Trial
    Li, Zhanguo
    Zhang, Fengchun
    Kay, Jonathan
    Fei, Kaiyin
    Han, Chenglong
    Zhuang, Yanli
    Wu, Zhong
    Hsia, Elizabeth C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S598 - S599
  • [39] SAFETY AND EFFICACY OF SUBCUTANEOUS GOLIMUMAB IN CHINESE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE MTX THERAPY: RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3 TRIAL
    Li, Z.
    Zhang, F.
    Kay, J.
    Fei, K.
    Han, C.
    Zhuang, Y.
    Wu, Z.
    Hsia, E. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 444 - 444
  • [40] Efficacy of leflunomide 100 mg weekly compared to low dose methotrexate in patients with active rheumatoid arthritis. Double blind, randomized clinical trial
    Jaimes-Hernandez, Jorge
    Irene Melendez-Mercado, Claudia
    Mendoza-Fuentesa, Angelica
    Aranda-Pereira, Pablo
    Castaneda-Hernandez, Gilberto
    REUMATOLOGIA CLINICA, 2012, 8 (05): : 243 - 249
12345